99 related articles for article (PubMed ID: 21605124)
1. Dose-response effects of TPI ASM8 in asthmatics after allergen.
Gauvreau GM; Pageau R; Séguin R; Carballo D; Gauthier J; D'Anjou H; Campbell H; Watson R; Mistry M; Parry-Billings M; Killian K; Renzi PM
Allergy; 2011 Sep; 66(9):1242-8. PubMed ID: 21605124
[TBL] [Abstract][Full Text] [Related]
2. TPI ASM8 reduces eosinophil progenitors in sputum after allergen challenge.
Imaoka H; Campbell H; Babirad I; Watson RM; Mistry M; Sehmi R; Gauvreau GM
Clin Exp Allergy; 2011 Dec; 41(12):1740-6. PubMed ID: 21762225
[TBL] [Abstract][Full Text] [Related]
3. Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses.
Gauvreau GM; Boulet LP; Cockcroft DW; Baatjes A; Cote J; Deschesnes F; Davis B; Strinich T; Howie K; Duong M; Watson RM; Renzi PM; O'Byrne PM
Am J Respir Crit Care Med; 2008 May; 177(9):952-8. PubMed ID: 18244953
[TBL] [Abstract][Full Text] [Related]
4. Advantageous toxicity profile of inhaled antisense oligonucleotides following chronic dosing in non-human primates.
Guimond A; Viau E; Aubé P; Renzi PM; Paquet L; Ferrari N
Pulm Pharmacol Ther; 2008 Dec; 21(6):845-54. PubMed ID: 18761414
[TBL] [Abstract][Full Text] [Related]
5. Effect of a very late antigen-4 receptor antagonist on allergen-induced airway responses and inflammation in asthma.
Diamant Z; Kuperus J; Baan R; Nietzmann K; Millet S; Mendes P; Miller B; Amin D; Rohatagi S; Sterk PJ; Hoogsteden HC; Prins JB
Clin Exp Allergy; 2005 Aug; 35(8):1080-7. PubMed ID: 16120091
[TBL] [Abstract][Full Text] [Related]
6. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
7. Safety and application of induced sputum analysis in childhood asthma.
Covar RA; Spahn JD; Martin RJ; Silkoff PE; Sundstrom DA; Murphy J; Szefler SJ
J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
[TBL] [Abstract][Full Text] [Related]
8. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
[TBL] [Abstract][Full Text] [Related]
9. Effect of an inhaled adenosine A2A agonist on the allergen-induced late asthmatic response.
Luijk B; van den Berge M; Kerstjens HA; Postma DS; Cass L; Sabin A; Lammers JW
Allergy; 2008 Jan; 63(1):75-80. PubMed ID: 17944983
[TBL] [Abstract][Full Text] [Related]
10. The effect of a single inhaled dose of a VLA-4 antagonist on allergen-induced airway responses and airway inflammation in patients with asthma.
Ravensberg AJ; Luijk B; Westers P; Hiemstra PS; Sterk PJ; Lammers JW; Rabe KF
Allergy; 2006 Sep; 61(9):1097-103. PubMed ID: 16918513
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between sputum eosinophils and responses to treatment of inhaled glucocorticoids in patients with persistent asthma].
Jiang YW; Sun YC; Zhou QT; Gai XY; Cao WL; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):447-51. PubMed ID: 17673020
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled fluticasone propionate on CTLA-4-positive CD4+CD25+ cells in induced sputum in mild asthmatics.
Kawayama T; Kinoshita T; Imaoka H; Gauvreau GM; O'Byrne PM; Aizawa H
Respirology; 2008 Nov; 13(7):1000-1007. PubMed ID: 18699801
[TBL] [Abstract][Full Text] [Related]
13. Magnitude of late asthmatic response to allergen in relation to baseline and allergen-induced sputum eosinophilia in mild asthmatic patients.
Dente FL; Bacci E; Bartoli ML; Cianchetti S; Di Franco A; Costa F; Vagaggini B; Paggiaro PL
Ann Allergy Asthma Immunol; 2008 May; 100(5):457-62. PubMed ID: 18517078
[TBL] [Abstract][Full Text] [Related]
14. Safety, pharmacodynamics and pharmacokinetics of TPI 1020 in smokers with asthma.
Boulet LP; Lemière C; Gauvreau G; Olivenstein R; Lougheed D; Paradis B; O'Byrne P; Pageau R; Renzi PM
Respir Med; 2009 Aug; 103(8):1159-66. PubMed ID: 19286361
[TBL] [Abstract][Full Text] [Related]
15. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
[TBL] [Abstract][Full Text] [Related]
16. Comparison between allergen-induced and exercise-induced asthma with respect to the late asthmatic response, airway responsiveness, and Creola bodies in sputum.
Tateishi K; Motojima S; Kushima A; Fukuda T; Makino S
Ann Allergy Asthma Immunol; 1996 Sep; 77(3):229-37. PubMed ID: 8814050
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of fluticasone and montelukast on allergen-induced asthma.
Palmqvist M; Bruce C; Sjöstrand M; Arvidsson P; Lötvall J
Allergy; 2005 Jan; 60(1):65-70. PubMed ID: 15575933
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils in bronchial mucosa of asthmatics after allergen challenge: effect of anti-IgE treatment.
van Rensen EL; Evertse CE; van Schadewijk WA; van Wijngaarden S; Ayre G; Mauad T; Hiemstra PS; Sterk PJ; Rabe KF
Allergy; 2009 Jan; 64(1):72-80. PubMed ID: 19076931
[TBL] [Abstract][Full Text] [Related]
19. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
20. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
